TAREN KEEBLER: Open Payments
NPI 1285167890 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 37 payments from 10 companies in 2025. Trend: 2023 $970 · 2024 $1,017 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $360 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $279 |
| Amgen Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| PFIZER INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: LifeVest, FARXIGA, LOKELMA, REPATHA, WAINUA, LEQVIO, VERQUVO, FUROSCIX.
Industry payments across TN — which companies pay providers there.
